Panel Discussion: Examining the Potential for the Treat and Reduce Obesity Act to be Passed and the Implications of this Act on Market Access
Time: 12:00 pm
day: Conference Day Two
Details:
- Analysing the potential impact of TROA on market access for AOMs and how expanded Medicare coverage could influence private payer behaviour
- Discussing the challenges of estimating the budgetary impact of the TROA, considering utilization rates, drug pricing and long-term cost savings associated with obesity reduction
- Understanding how the TROA could impact the pharmaceutical industry’s investment and development of new AOMs to double down on portfolio strategy and potential future pricing agreements
